+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biobanks Market Research Report by Component, by Sample Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4989810
  • Report
  • July 2021
  • Region: Global
  • 188 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Biobanks Market will Grow to USD 94.61 Billion by 2026, at a CAGR of 11.61%

FEATURED COMPANIES

  • Beckman Coulter, Inc
  • BioCision
  • BioLife Solutions, Inc
  • Merck KGaA
  • Tecan AG
The Global Biobanks Market size was estimated at USD 48.94 Billion in 2020 and expected to reach USD 54.45 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 11.61% to reach USD 94.61 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Biobanks to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Component, the Biobanks Market was studied across Consumables, Equipment, Services, and Software.
  • Based on Application, the Biobanks Market was studied across Clinical Research, Life Science Research, and Regenerative Medicine.
  • Based on Sample Type, the Biobanks Market was studied across Biological Fluids, Blood Products, Cell Lines, Human Tissues, and Nucleic Acids.
  • Based on Region, the Biobanks Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biobanks Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biobanks Market, including Beckman Coulter, Inc, Becton, Dickinson and Company, BioCision, BioLife Solutions, Inc, LVL Technologies GmbH & Co. KG, Merck KGaA, Panasonic Healthcare Holdings Co. Ltd, Taylor-Wharton International LLC, Tecan AG, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Biobanks Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biobanks Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biobanks Market?
4. What is the competitive strategic window for opportunities in the Global Biobanks Market?
5. What are the technology trends and regulatory frameworks in the Global Biobanks Market?
6. What is the market share of the leading vendors in the Global Biobanks Market?
7. What modes and strategic moves are considered suitable for entering the Global Biobanks Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Beckman Coulter, Inc
  • BioCision
  • BioLife Solutions, Inc
  • Merck KGaA
  • Tecan AG
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Component Outlook
3.4. Application Outlook
3.5. Sample Type Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in incidence of chronic disease
5.1.1.2. Rising awareness about biobanks
5.1.1.3. Growing genomic research activities
5.1.2. Restraints
5.1.2.1. High Cost of Automation
5.1.2.2. Ethical and legal issues related to biobanking
5.1.3. Opportunities
5.1.3.1. Growing focus on the R&D of advanced therapies
5.1.3.2. Increasing public awareness about genomic testing and stem cell therapies
5.1.3.3. Increasing population coupled with presence of a large geriatric population base
5.1.4. Challenges
5.1.4.1. Long-Term Sustainability of Biobanks
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Biobanks Market, by Component
6.1. Introduction
6.2. Consumables
6.3. Equipment
6.4. Services
6.5. Software

7. Biobanks Market, by Application
7.1. Introduction
7.2. Clinical Research
7.3. Life Science Research
7.4. Regenerative Medicine

8. Biobanks Market, by Sample Type
8.1. Introduction
8.2. Biological Fluids
8.3. Blood Products
8.4. Cell Lines
8.5. Human Tissues
8.6. Nucleic Acids

9. Americas Biobanks Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Biobanks Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Biobanks Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Beckman Coulter, Inc
13.2. Becton, Dickinson and Company
13.3. BioCision
13.4. BioLife Solutions, Inc
13.5. LVL Technologies GmbH & Co. KG
13.6. Merck KGaA
13.7. Panasonic Healthcare Holdings Co. Ltd
13.8. Taylor-Wharton International LLC
13.9. Tecan AG
13.10. Thermo Fisher Scientific Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL BIOBANKS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2020 (USD BILLION)
FIGURE 3. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
FIGURE 4. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2020 (USD BILLION)
FIGURE 5. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 6. GLOBAL BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 7. GLOBAL BIOBANKS MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL BIOBANKS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2020 VS 2026 (%)
FIGURE 10. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2020 VS 2026 (USD BILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2026
FIGURE 12. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, 2018-2026 (USD BILLION)
FIGURE 13. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 14. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2026 (USD BILLION)
FIGURE 15. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 16. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL BIOBANKS MARKET SIZE, BY SOFTWARE, 2018-2026 (USD BILLION)
FIGURE 19. GLOBAL BIOBANKS MARKET SIZE, BY SOFTWARE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 20. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 21. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2026
FIGURE 23. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2026 (USD BILLION)
FIGURE 24. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 25. GLOBAL BIOBANKS MARKET SIZE, BY LIFE SCIENCE RESEARCH, 2018-2026 (USD BILLION)
FIGURE 26. GLOBAL BIOBANKS MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 27. GLOBAL BIOBANKS MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL BIOBANKS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 29. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2020 VS 2026 (%)
FIGURE 30. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2026
FIGURE 32. GLOBAL BIOBANKS MARKET SIZE, BY BIOLOGICAL FLUIDS, 2018-2026 (USD BILLION)
FIGURE 33. GLOBAL BIOBANKS MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 34. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD PRODUCTS, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD PRODUCTS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, 2018-2026 (USD BILLION)
FIGURE 37. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 38. GLOBAL BIOBANKS MARKET SIZE, BY HUMAN TISSUES, 2018-2026 (USD BILLION)
FIGURE 39. GLOBAL BIOBANKS MARKET SIZE, BY HUMAN TISSUES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 40. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACIDS, 2018-2026 (USD BILLION)
FIGURE 41. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 42. AMERICAS BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. ARGENTINA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. BRAZIL BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. CANADA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. MEXICO BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. UNITED STATES BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. ASIA-PACIFIC BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. AUSTRALIA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. CHINA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. INDIA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. INDONESIA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. JAPAN BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. MALAYSIA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. PHILIPPINES BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. SINGAPORE BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. SOUTH KOREA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. THAILAND BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. FRANCE BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. GERMANY BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. ITALY BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. NETHERLANDS BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. QATAR BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. RUSSIA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. SAUDI ARABIA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. SOUTH AFRICA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 68. SPAIN BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 69. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 70. UNITED KINGDOM BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 71. GLOBAL BIOBANKS MARKET: FPNV POSITIONING MATRIX
FIGURE 72. GLOBAL BIOBANKS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 73. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOBANKS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL BIOBANKS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL BIOBANKS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL BIOBANKS MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL BIOBANKS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL BIOBANKS MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD PRODUCTS, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL BIOBANKS MARKET SIZE, BY HUMAN TISSUES, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. AMERICAS BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. ARGENTINA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. BRAZIL BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. CANADA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. MEXICO BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. UNITED STATES BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. ASIA-PACIFIC BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. AUSTRALIA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. CHINA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. INDIA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. INDONESIA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. JAPAN BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. MALAYSIA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. PHILIPPINES BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. SINGAPORE BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. SOUTH KOREA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. THAILAND BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. FRANCE BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. GERMANY BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. ITALY BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. NETHERLANDS BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. QATAR BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. RUSSIA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. SAUDI ARABIA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. SOUTH AFRICA BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. SPAIN BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. UNITED ARAB EMIRATES BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. UNITED KINGDOM BIOBANKS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. GLOBAL BIOBANKS MARKET: SCORES
TABLE 49. GLOBAL BIOBANKS MARKET: BUSINESS STRATEGY
TABLE 50. GLOBAL BIOBANKS MARKET: PRODUCT SATISFACTION
TABLE 51. GLOBAL BIOBANKS MARKET: RANKING
TABLE 52. GLOBAL BIOBANKS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 53. GLOBAL BIOBANKS MARKET: MERGER & ACQUISITION
TABLE 54. GLOBAL BIOBANKS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 55. GLOBAL BIOBANKS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 56. GLOBAL BIOBANKS MARKET: INVESTMENT & FUNDING
TABLE 57. GLOBAL BIOBANKS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 58. GLOBAL BIOBANKS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Beckman Coulter, Inc
  • Becton, Dickinson and Company
  • BioCision
  • BioLife Solutions, Inc
  • LVL Technologies GmbH & Co. KG
  • Merck KGaA
  • Panasonic Healthcare Holdings Co. Ltd
  • Taylor-Wharton International LLC
  • Tecan AG
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll